Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells

Leukemia and Lymphoma

Volumn 15, Issue 1-2, 1994, Pages 21-32

  Solary, Eric ^a   Bertrand, Richard ^b   Pommier, Yves ^c  

^a Laboratory of Oncohematology University of Medicine ^*  (France)

^b NOTRE DAME HOSPITAL   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CYCLOHEXIMIDE; CYTOTOXIC AGENT; DACTINOMYCIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); ENDONUCLEASE; ENZYME INHIBITOR; ETOPOSIDE; GYRASE INHIBITOR; PHORBOL ESTER; PROTEIN P53;

APOPTOSIS; CELL DIFFERENTIATION; CELL STRAIN HL 60; CHROMATIN STRUCTURE; DNA CLEAVAGE; DNA DAMAGE; DNA DEGRADATION; DRUG CYTOTOXICITY; DRUG SENSITIVITY; HUMAN; LEUKEMIA CELL LINE; MACROPHAGE; MITOSIS INHIBITION; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CHROMATIN; DNA DAMAGE; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DNA, NEOPLASM; GLUCOCORTICOIDS; HUMAN; LEUKEMIA, PROMYELOCYTIC, ACUTE; NEOPLASM PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN P53; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0027936034     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199409051674     Document Type: Article

References (140)

1. Bcl-2-An Antidote to Programmed Cell Death
2. Endogenous endonuclease-induced DNA fragmentation: An early event in cell-mediated cytolysis
3. HL-60 Cells induced to differentiate towards neutrophils subsequently die via apoptosis
4. Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle
5. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes
6. Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells
7. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia
8. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note
9. bcl-2 Modulation of apoptosis induced by anticancer drugs—Resistance to thymidylate stress is independent of classical resistance pathways
10. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair
11. Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis
12. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
13. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli
14. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors
15. Control of programmed cell death in normal and leukemic cells-new implications for therapy
16. The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation and cellular oncogene expression
17. Growth and differentiation of human myeloid leukemia cell line HL60
18. Eto-poside-induced apoptosis in human HL-60 cells is associated with intracellular acidification
19. The concentration-dependent diversity of effects of DNA to-poisomerase I and II inhibitors on the cell cycle of HL-60 cells
20. Camptothecin, teniposide, or 4′-(9-acridinylamino)-3-methanesulfon-m-an-isidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells
21. Cell death induced by topoisomerase inhibitors. Role of calcium in mammalian cells
22. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors
23. Effects of combined treatments with topoisomerase I and II inhibitors in human colon carcinoma HT-29 cells
24. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression
25. Ultraviolet B irradiation of human leukaemia HL-60 cells in vitro induces apoptosis
26. Induction of apoptosis (Programmed Cell Death) in human leukemic cells by inhibition of RNA or protein synthesis
27. Elevations in cytosolic free Ca2+ are not required to trigger apoptosis in human leukaemia cells
28. The cell cycle related differences in susceptibility of HL-60-cells to apoptosis induced by various antitumor agents
29. Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors
30. Mammalian DNA topoisomerase I and its inhibitors
31. Topoisomerase II inhibition by antitumor intercalators and demethylepipodo-phyllotoxins
32. DNA topoisomerases I and II in cancer chemotherapy: Update and perspectives
33. DNA topoisomerase poisons as antitumor drugs
34. Dual topoisomerase I and II inhibition by intoplicine (RP-60475) a new antitumor agent in early clinical trials
35. Production of protein-associated DNA breaks by 10-[diethyl-aminopropylamino]-6-methyl-5H-pyrido[3′,4′:4,5]pyrrolo[2,3-gjisoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors
36. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4
37. New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site
38. When good enzymes go bad: Conversion of topoisomerase II to a cellular toxin by antineoplastic drugs
39. Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin
40. Local DNA sequence requirements for topoisomerase H-induced DNA cleavage produced by amsacrine and teniposide
41. Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin
42. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II
43. Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin
44. Protein-linked DNA strand breaks produced by etoposide and teniposide in Mouse LI210 and Human VA-13 and HT-29 cell lines: relationship to cytotoxicity
45. Effects of dimethyl sulfoxide and thiourea upon intercalator-induced DNA single-strand breaks in mouse leukemia (L1210) cells
46. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: Comparison with adriamy-cin and 4′-(9-acridinylamino)methanesulfon-m-anisidide
47. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells
48. Arrest of DNA replication by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin
49. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons
50. Antagonism between camptothecin and topoisomerase H-directed chemotherapeutic agents in a human leukemia cell line
51. Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA
52. The mechanisms of formation of chromosomal aberrations: Role of eukaryotic DNA topoisomerases
53. Abrogation of etoposide-mediated cytotoxicity by cycloheximide
54. Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia
55. Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9; 11 translocation
56. Acute nonlymphcytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small cell carcinoma of the lung
57. Secondary leukemia associated with a conventional dose of etoposide: Review of a serial germ cell tumor protocols
58. Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumors
59. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation
60. Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia
61. Signaling for death of lymphoid cells
62. Posttranscriptional regulation of colony-stimulating factor-1 (CSF-1) and CSF-1 receptor gene expression during inhibition of phorbolester-induced monocytic differentiation by dexamethasone and cyclosporin A: Potential involvement of a destabilizing protein
63. Dexamethasone-in-duced increase in platelet-derived growth factor (B) mRNA in human alveolar macrophages and myelomonocytic HL60 macrophage-like cells
64. Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1-beta) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethazone: Dissociation of acivicin-induced TNF-alpha and IL-I beta mRNA expression from acivicin-induced monocytoid differentiation
65. Expression of differentially phosphorylated Rb and mutant p53 proteins in myeloid leukemia cell lines
66. P53-dependent apoptosis modulates the cytotoxicity of anticancer agents
67. A death in the life of p53
68. Molecular regulation of apoptosis: Genetic control of cell death
69. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by in-terleukin-6
70. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics
71. Cell death by apoptosis and its protective role against disease
72. Radiolabeling of DNA can induce its fragmentation in HL-60 human promyelocytic leukemic cells
73. Induction of differentiation and DNA strand breakage in human HL-60 and K562 leukemia cells by genistein
74. Taxol induces inter-nucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells
75. Disruption of microtubules induces an endogenous suicide pathway in human leukaemia HL-60 cells
76. Apoptosis: The role of the endonuclease
77. Endonuclease activation during apoptosis: The role of cytosolic Ca2+ and pH
78. Identification of ae-oxyribonuclease II as an endonuclease involved in apoptosis
79. The apoptosis endonuclease and its regulation
80. Isolation and purification of calcium and magnesium-dependent endonuclease from rat liver nuclei
81. Dexa-methasone-induced apoptosis involves cleavage of DNA to large fragments prior to intemucleosomal fragmentation
82. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of intemucleosomal fragmentation
83. Diassembly of chromatin into 50 KB units by detergent
84. The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow
85. The meta-phase scaffold is helically folded: Sister chromatids have predominantly opposite helical handedness
86. Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites
87. A biochemical hallmark of apop-tosis: Internucleosomal degradation of the genome
88. Teniposide induces nuclear but not mitochondrial DNA degradation
89. The origins of DNA breaks: A consequence of DNA damage, DNA repair, or apoptosis?
90. Mechanism of tissue-specific induction of internucleosomal deoxyribonucleic acid cleavage activity and apoptosis by glucocorticoids
91. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death)
92. DNA fragmentation during apoptosis is caused by frequent single-strand cuts
93. The involvement of nuclear nucleases in rat thymocyte DNA degradation after y-irradiation
94. Calcium-activated DNA fragmentation kills immature thymocytes
95. Programmed cell death of nonproliferating an-drogen-independent prostatic cancer cells
96. Identification of a glucocorticoid-induced nuclease in thymocytes; A potential “Lysis Gene” product
97. Inhibition of both etoposide-induced DNA fragmentation and activation of poly(ADP-ribose) synthesis by zinc ion
98. Spermine prevents endonuclease activation and apoptosis in thymocytes
99. Inhibition of apoptosis by zinc: a reappraisal
100. Programmed cell death induced by ceramide
101. Chelation of intracellular zinc triggers apoptosis in mature thymocytes
102. Mutant cells defective in poly(ADP-ribose) synthesis due to stable alterations in enzyme activity or substrate availability
103. Evidence for adenosine diphosphate ribosylation of Ca2+, Mg2 +-dependent endonuclease
104. Topological complexes between DNA and topoisomerase II and effects of polyamines
105. Specific proteolytic cleavage of poly(ADP-ribose) polymerase—An early marker of chemotherapy-induced apoptosis
106. Identification, purification, and characterization of a calcium-dependent endonuclease (NUC18) from apoptotic rat thymocytes: NUC18 is not histone H2B
107. Ubiquitin pathway involvement in human lymphocyte gamma-irradiation-induced apoptosis
108. SGP2, ubiquitin, 14K lectin and RP8 mRNAs are not induced in neuronal apoptosis
109. A morphological and immunohistochemical study of programmed cell death in Botryllus schlosseri (Tunicata, As-cidiacea)
110. DNA fragmentation induced by cytotoxic T lymphocytes can result in target cell death
111. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions
112. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A
113. Molecular Genetics of Cell Death in the Nematode Caenorhabditis elegans
114. Mechanisms and functions of cell death
115. Interaction of DNA intercalator 3-nitrobenzothiazolo (3,2-a)quinolinium with DNA topoisomerases: A possible-mechanism for its biological activity
116. A DNA topoisomerase I inhibitor blocks the differentiation of rat granulosa cells induced by follicle-stimulating hormone
117. Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases
118. Differentiation induction of human promyelocytic leukemia cells by 10-hydroxycamptothecin, a DNA topoisomerase I inhibitor
119. Studies of the differentiation properties of camptothecin in the human leukaemic cells K562
120. Topoisomerase inhibitors have potent differentiation-inducing activity for human and mouse myeloid leukemia cells
121. Synergistic induction of erythroid differentiation of mouse erythroleukemia (MEL) cells by inhibitors of topoisomerases and protein tyrosine kinases
122. Terminal Differentiation of Human Promyelocytic Leukemia Cells Induced by Dimethylsulfoxide and Other Polar Compounds
123. Differing responses of G2-related genes during differentiation of HL60 cells by TPA or DMSO
124. A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells
125. Specific protein de-phosphorylation in apoptosis induced by ionizing radiation and heat shock in human lymphoid tumor lines
126. Phosphorylation of Human Topoisomerase I by Protein Kinase C In Vitro and in Phorpbol 12-myristate 13-acetate-activated HL-60 Promyelocytic Leukaemia Cells
127. Rapid Increase in the Activity of DNA Topoisomerase I, But Not Topoisomerase II, in HL-60 Promyelocytic Leukemia Cells Treated with a Phorbol Diester
128. Epidermal Growth Factor and Tumor Promoters Prevent DNA Fragmentation by Different Mechanisms
129. Induction of Apoptosis in Chronic Lymphocytic Leukemia Cells and Its Prevention by Phorbol Ester
130. Phorbol Esters Inhibit Apoptosis In IL-2-Dependent T Lymphocytes
131. Constitutive c-myc Expression in an IL-3-Dependent Myeloid Cell Line Suppresses Cell Cycle Arrest and Accelerates Apoptosis
132. Regulation by bcl-2, c-myc, and pS3 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and-defective myeloid leukemic cells
133. Cancer. A death in the life of p53 [news; comment]
134. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by in-terleukin-6
135. cis-Diamminedichloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway
136. Involvement of reactive oxygen intermediates in the induction of c-jun gene transcription by ionizing radiation [published erratum appears in Biochemistry (1992 Oct 6) 31 (39), 9512]
137. Response to adversity: Molecular control of gene activation following genotoxic stress
138. bcl-2 Gene expression in hematopoietic cell differentiation
139. Bcl-2 Oncoprotein Blocks Chemotherapy-induced apoptosis in a human leukemia cell line
140. Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity